Wittchen H U, Kessler R C, Zhao S, Abelson J
Max-Planck-Institut für Psychiatrie, Klinisches Institut, München, Germany.
J Psychiatr Res. 1995 Mar-Apr;29(2):95-110. doi: 10.1016/0022-3956(94)00044-r.
This is the first in a series of reports on the long-term test-retest reliability and procedural validity of the UM-CIDI, a modified version of the Composite International Diagnostic Interview used in the US National Comorbidity Survey (NCS). This report focuses on DSM-III-R Generalized Anxiety Disorder (GAD). The NCS administered the UM-CIDI to a nationally representative sample of 8098 respondents in the age range 15-54. A subsample of 36 respondents was subsequently selected for clinical reappraisal of GAD, consisting of reinterviewing by a clinical reappraisal interviewer who blindly readministered the GAD section of the UM-CIDI followed by an expanded version of the GAD section of the Structured Clinical Interview for DSM-III-R (SCID). The test-retest reliability of UM-CIDI/DSM-III-R lifetime GAD is Kappa = .53. When the requirement that the worries be excessive or unrealistic (A2) is removed, as in ICD-10 and partially in DSM-IV, reliability increases to Kappa = .78. The concordance between the baseline UM-CIDI diagnosis and the SCID diagnosis is Kappa = .35, while the cross-sectional concordance is Kappa = .47 (.66 when the Criterion A2 requirement is removed). Item-level analysis shows that lack of concordance between the UM-CIDI and the SCID is due largely to Criteria A2 and D. The A2 problem could be addressed either by deemphasizing the cognitive-evaluative component of GAD as in ICD-10, or by removing consideration of the term "unrealistic" from the criterion as in DSM-IV and more clearly specifying the meaning of the term "excessive". These options require further research on similarities and differences in risk factors, course, family history, and treatment response of more narrowly and broadly defined GAD. The Criterion D problem is due to lack of clarity in what constitutes a symptom occurring "often". This is clarified in DSM-IV. It is likely that this clarification will make it possible to develop more precisely structured questions to evaluate Criterion D in subsequent revisions of the UM-CIDI, resulting in improved reliability and validity.
这是关于UM-CIDI长期重测信度和程序效度系列报告中的第一篇。UM-CIDI是美国国家共病调查(NCS)中使用的综合国际诊断访谈的修订版。本报告聚焦于《精神疾病诊断与统计手册》第三版修订本(DSM-III-R)中的广泛性焦虑障碍(GAD)。NCS对年龄在15至54岁之间的8098名具有全国代表性的受访者进行了UM-CIDI测试。随后,从这些受访者中选取了36人的子样本进行GAD的临床重新评估,包括由一名临床重新评估访谈者进行再次访谈,该访谈者盲目重新施测UM-CIDI的GAD部分,随后进行《精神疾病诊断与统计手册》第三版修订本(DSM-III-R)结构化临床访谈(SCID)的GAD部分扩展版。UM-CIDI/DSM-III-R终身GAD的重测信度为Kappa = 0.53。当去除担忧必须过度或不现实(A2)这一要求时,如同在《国际疾病分类》第十版(ICD-10)以及部分程度上在《精神疾病诊断与统计手册》第四版(DSM-IV)中那样,信度提高到Kappa = 0.78。基线UM-CIDI诊断与SCID诊断之间的一致性为Kappa = 0.35,而横断面一致性为Kappa = 0.4(去除标准A2要求时为0.66)。项目层面分析表明,UM-CIDI与SCID之间缺乏一致性主要归因于标准A2和D。A2问题可以通过像ICD-10那样淡化GAD的认知评估成分来解决,或者像DSM-IV那样从标准中去除对“不现实”一词的考量,并更明确地规定“过度”一词的含义来解决。这些选择需要对更狭义和广义定义的GAD在危险因素、病程、家族史和治疗反应方面的异同进行进一步研究。标准D问题是由于对什么构成“经常”出现的症状缺乏明确界定。这在DSM-IV中得到了澄清。很可能这一澄清将使得在UM-CIDI的后续修订版中能够开发出更精确结构化的问题来评估标准D,从而提高信度和效度。